Aptargroup Inc (NYSE: ATR) on Friday, plunged -0.32% from the previous trading day, before settling in for the closing price of $125.11. Within the past 52 weeks, ATR’s price has moved between $103.23 and $164.28.
Healthcare Sector giant saw their annual sales surged by 8.59% over the last five years. The company achieved an average annual earnings per share of 1.27%. With a float of $64.97 million, this company’s outstanding shares have now reached $65.60 million.
Aptargroup Inc (ATR) Insider Activity
Observing investor behavior towards Medical Instruments & Supplies industry stocks is more important than anything else. The insider ownership of Aptargroup Inc is 0.99%, while institutional ownership is 93.60%. The most recent insider transaction that took place on Dec 12 ’25, was worth 1,818,435. In this transaction Chief Accounting Officer of this company sold 15,000 shares at a rate of $121.23, taking the stock ownership to the 29,607 shares. Before that another transaction happened on Dec 12 ’25, when Company’s Officer proposed sale 15,000 for $121.23, making the entire transaction worth $1,818,435.
Aptargroup Inc (ATR) Earnings and Forecasts
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported 1.52 earnings per share (EPS) for the period topping the consensus outlook (set at 1.26) by 0.26. Wall Street market experts anticipate that the next fiscal year will bring earnings of 1.17 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 1.27% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 5.69% during the next five years compared to 8.59% growth over the previous five years of trading.
Aptargroup Inc (NYSE: ATR) Trading Performance Indicators
Aptargroup Inc (ATR) is currently performing well based on its current performance indicators. A quick ratio of 0.82 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.23. Likewise, its price to free cash flow for the trailing twelve months is 25.99.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 6.24, a number that is poised to hit 1.23 in the next quarter and is forecasted to reach 5.68 in one year’s time.
